Variant Phenotype Annotation
证据URL
https://www.pharmgkb.org/variantAnnotation/1444709399
总结
CYP2D6 *4/*4 is associated with decreased progression-free survival when treated with anthracyclines and related substances and tamoxifen in women with Breast Neoplasms as compared to CYP2D6 *1/*1 + *1/*4.